Location History:
- Lincoln University, PA (US) (1996)
- Canton, MI (US) (1993 - 1997)
Company Filing History:
Years Active: 1993-1997
Title: Edgardo Laborde: Innovator in Antibacterial Agents
Introduction
Edgardo Laborde is a notable inventor based in Canton, MI (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of antibacterial agents. With a total of 6 patents to his name, Laborde's work has had a meaningful impact on pharmaceutical research.
Latest Patents
Among his latest patents, Laborde has developed compounds such as 7-substituted quinolones and naphthyridones, which serve as effective antibacterial agents. One of his notable inventions includes a compound of the formula ##STR1##, where * denotes an asymmetric carbon, and X can be various substituents like C--H, C--F, C--Cl, C--OCH.sub.3, C--CF.sub.3, or N. Additionally, he has worked on the preparation of stereochemically pure oximes with muscarinic activity. This invention focuses on the selective formation of the Z-oxime and O-alkylation of 1-azabicyclo 2.2.1 heptan-3-one and 1-azabicyclo 2.2.2 heptan-3-one oximes, producing compounds with muscarinic activity. The process is designed for industrial scale-up, providing better yields and ease of preparation.
Career Highlights
Laborde is associated with Warner-Lambert Company, where he has been instrumental in advancing research in antibacterial compounds. His innovative approaches have contributed to the development of new therapeutic agents that address bacterial infections.
Collaborations
Throughout his career, Laborde has collaborated with esteemed colleagues, including Mel C Schroeder and Ruth Bucsh. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.
Conclusion
Edgardo Laborde's contributions to the field of medicinal chemistry, particularly in antibacterial agents, highlight his innovative spirit and dedication to improving healthcare. His patents and collaborations reflect a commitment to advancing pharmaceutical research and development.